Skip to main content
. 2004 Jan 20;90(2):343–347. doi: 10.1038/sj.bjc.6601469

Figure 1.

Figure 1

Observed topotecan concentrations (data points) and model-predicted concentrations using the interoccasion variability option: data from one patient with minimal (−9%, A) or large (+104%, B) change of AUC after administration of the same dose at days 1 and 5 (1.5 mg m−2).